We examine the impact of pharmaceutical innovation on the longevity of Australians during the period 1995-2003. Due to the government's Pharmaceutical Benefits Scheme, Australia has much better data o
Analysis of the timing of launches of 642 new drugs in 76 countries during 1983-2002 shows that patent and price regulation regimes strongly affect how quickly new drugs become commercially available
This study aimed to examine the factors that may influence physicians’ choice of antidiabetic agents. In addition, we investigated physicians’ decision-making process and treatment of T2DM patients wi
Additional file 3: Table S2. Estimated Average Health Care Utilization and Out-of-pocket Medical Spending Difference in Medical Aid Type II panel by difference-in-differences analysis. * Log Link with
